Xcellerant Ventures Invests In Series A Funding Round For Lenoss Medical
Dec 13, 2023•about 2 years ago
Round Type
series a
Investors
John WilliamsXcellerant Ventures
Description
Xcellerant Ventures welcomes Lenoss Medical into our Venture Fund I portfolio. Lenoss Medical is disrupting the treatment of spinal fractures with their OsteoPearl VBA System. This minimally invasive and cement-free technology delivers a fully biologic solution to stabilize spinal fractures and utilizes the natural healing properties of healthy bone. “There is no longer a need to utilize cement to treat osteoporotic spinal fractures
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers